NTNG1 and neoplasm: Recent studies have shown that Netrin G1 (NetG1) is the promoter of PDAC tumorigenesis in CAFs-related TME, and NetG1+CAFs stimulate immunosuppressive response and promote tumor progression through NetG1-mediated effects on glutamate/glutamine metabolism.